Spillover adherence effects of fixed-dose combination HIV therapy
Patient Preference and Adherence, 2012 Teresa L Kauf1, Keith L Davis2, Stephanie R Earnshaw2, E Anne Davis31Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, 2RTI Health Solutions, Research Triangle Park, NC, 3Independent consultant,
Kauf TL, Davis KL, Earnshaw SR, Davis EA
doaj +1 more source
Diabetes, Metabolic Syndrome and Obesity, 2010 Robert G MosesClinical Trials and Research Unit, South East Sydney and Illawarra Area Health Service, New South Wales, AustraliaAbstract: Type 2 diabetes is a progressive disease associated with high levels of morbidity and mortality and for which there ...
Robert G Moses
doaj +1 more source
PLoS ONE, 2021 BackgroundSuboptimal patient adherence to pharmacological therapy of type 2 diabetes may be due in part to pill burden. One way to reduce pill burden in patients who need multiple medications is to use fixed-dose combinations.
Anna-Katharina Böhm +3 more
doaj +2 more sources
Drug Design, Development and Therapy, 2019 Minkyung Oh,1 Jae-Gook Shin,1,2 Sangzin Ahn,1 Bo Hoon Kim,3 Ji Yeon Kim,3 Hyun Ju Shin,4 Hyun Ju Shin,4 Jong-Lyul Ghim1,21Department of Pharmacology and PharmacoGenomics Research Center, Inje University College of Medicine, Busan, Republic of Korea ...
Oh M +7 more
doaj +1 more source
Fixed-dose combination of sitagliptin and metformin for the treatment of type 2 diabetes
Diabetes, Metabolic Syndrome and Obesity, 2009 Jonathan K ReynoldsWashington State University, College of Pharmacy, Pullman, WA, USAAbstract: JanumetTM, a fixed dose combination of sitagliptin/metformin HCL manufactured by Merck Pharmaceuticals, has received US Food and Drug Administration approval ...
Jonathan K Reynolds
doaj +1 more source
Review of dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic hyperplasia: efficacy, safety, and patient acceptability [PDF]
Patient Preference and Adherence, 2011 Jack BarkinHumber River Regional Hospital, Toronto, Canada and Department of Surgery, University of Toronto, Toronto, Ontario, CanadaAbstract: Lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH) will usually affect older men,
Barkin J
doaj +2 more sources
Vascular Health and Risk Management, 2010 Peter Bramlage1, Wolf-Peter Wolf2, Thomas Stuhr2, Eva-Maria Fronk3, Wolfhard Erdlenbruch2, Reinhard Ketelhut4, Roland E Schmieder51Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow; 2Daiichi Sankyo Deutschland GmbH, Munich, Germany ...
Peter Bramlage +3 more
doaj +1 more source
Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children [PDF]
, 2008 BackgroundCombination therapies are frequently recommended as maintenance therapy for people with asthma, whose disease is not adequately controlled with inhaled steroids.
Christopher J Cates +7 more
core +1 more source
Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia [PDF]
, 2015 Konstantinos Dimitropoulos, Stavros Gravas Department of Urology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece Abstract: Treatment of male lower urinary tract symptoms (LUTS) has traditionally focused on the ...
Dimitropoulos, K. +3 more
core +1 more source
Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial. [PDF]
, 2011 BACKGROUND: The use of artemisinin-based combination therapy (ACT) is currently recommended for treating uncomplicated malaria. The objective was to assess the efficacy and safety of repeated administrations of two fixed-dose presentations of ACT ...
Gaye Oumar +32 more
core +1 more source